临床试验成像市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

临床试验成像市场按产品和服务(试验设计咨询服务、读取分析服务、操作成像服务、成像软件)、模式、最终用户和地理划分

市场快照

clinical trial imaging market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.5 %
middle east and africa clinical trial imaging market

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于合同研究机构数量的增加、研发支出的增加以及制药和生物技术公司的增长,临床试验影像市场将增长。

随着科学技术的不断进步,全球制药公司的数量不断增加。制药和生物技术公司数量的增加使得制造商必须向最终用户提供最好的药物或药品,因为竞争正在打击这些公司。随着这些公司正在进行大量新药发现,这一因素正在推动临床试验的兴起。

因此,药物发现数量的增加推动了在临床试验中实施成像技术的需求。这对越来越多的制药和生物技术公司产生了积极影响。

此外,整体监管框架的改进也影响了市场增长和临床试验中成像技术的接受度。

报告范围

根据报告的范围,临床试验成像现在是制药和生物技术行业研发过程的重要组成部分。医学影像的使用现已在临床试验中得到认可,以使试验更加有效和准确。

By Product and Service
Trial Design Consulting Services
Read Analysis Services
Operational Imaging Services
Imaging Software
By Modality
Magnetic Resonance Imaging
Computed Tomography
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities
By End-User
Pharmaceutical Companies
Medical Device Manufacturers
Academic and Government Research Institutes
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

计算机断层扫描有望见证快速增长

计算机断层扫描是一种非侵入性医疗程序,它利用 X 射线生成身体的横截面图像,并为治疗提供详细信息,并检查儿童和成人的异常情况。

计算机断层扫描 (CT) 段的增长归因于 CT 提供的广泛优势,例如药物活性研究和对损伤、癌症(肿瘤)和体内异常的筛查。此外,在临床研究和临床试验领域增加的资金和投资正在推动该细分市场的增长。这一细分市场的很大一部分还归因于 CT 在癌症(肿瘤)、损伤筛查方面的高度优势。

middle east and africa clinical trial imaging industry

预计北美将主导临床试验成像市场

由于慢性病患病率的上升以及老年人口的增加,这将刺激区域市场的增长,因此发现北美在临床试验成像市场中占据主导地位。除此之外,医疗基础设施的进步使慢性病的诊断和治疗速度更快。

然而,迄今为止,美国 FDA 和其他监管机构在取得试验注册的成就方面也发挥了主导作用,并且很可能在不久的将来得到支持来应对这些挑战。由于所有这些因素,预计区域市场将在整个预测期内保持其在市场中的地位。

middle east and africa clinical trial imaging market growth

竞争格局

所研究市场的主要参与者包括 Bioclinica Inc、Ixico PLC、Icon PLC、Intrinsic Imaging LLC、Radiant Sage LLC 和 Parexel International Corporation。这些主要参与者正在实施新产品发布、兼并和收购等增长战略,以保持份额和多样化产品组合。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growth in The Pharmaceutical and Biotechnological Companies

      2. 4.2.2 Rise in Number of Contract Research Organization

      3. 4.2.3 Increase in R&D Spending

    3. 4.3 Market Restraints

      1. 4.3.1 High Implementation Barriers and Costs of Imaging Systems

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product and Service

      1. 5.1.1 Trial Design Consulting Services

      2. 5.1.2 Read Analysis Services

      3. 5.1.3 Operational Imaging Services

      4. 5.1.4 Imaging Software

    2. 5.2 By Modality

      1. 5.2.1 Magnetic Resonance Imaging

      2. 5.2.2 Computed Tomography

      3. 5.2.3 Ultrasound

      4. 5.2.4 Positron Emission Tomography

      5. 5.2.5 X-Ray

      6. 5.2.6 Echocardiography

      7. 5.2.7 Other Modalities

    3. 5.3 By End-User

      1. 5.3.1 Pharmaceutical Companies

      2. 5.3.2 Medical Device Manufacturers

      3. 5.3.3 Academic and Government Research Institutes

      4. 5.3.4 Other End-Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bioclinica Inc.

      2. 6.1.2 Biomedical Systems Corporation

      3. 6.1.3 Biotelemetry Inc.

      4. 6.1.4 Cardiovascular Imaging Technologies LLC

      5. 6.1.5 Icon PLC

      6. 6.1.6 Intrinsic Imaging LLC

      7. 6.1.7 Ixico PLC

      8. 6.1.8 Parexel International Corporation

      9. 6.1.9 Radiant Sage LLC

      10. 6.1.10 Worldcare Clinical LLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Clinical Trial Imaging Market market is studied from 2018 - 2026.

The Clinical Trial Imaging Market is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bioclinica Inc., Radiant Sage LLC, Biotelemetry Inc., Cardiovascular Imaging Technologies LLC, Icon PLC are the major companies operating in Clinical Trial Imaging Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!